CareDx, Inc.CDNAEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CDNA Q3 2025 Key Financial Metrics
Revenue
$100.1M
Gross Profit
N/A
Operating Profit
$-246.0K
Net Profit
$1.7M
Gross Margin
N/A
Operating Margin
-0.2%
Net Margin
1.7%
YoY Growth
20.7%
EPS
$0.03
Financial Flow
CareDx, Inc. Q3 2025 Financial Summary
CareDx, Inc. reported revenue of $100.1M for Q3 2025, with a net profit of $1.7M (1.7% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $100.1M |
|---|---|
| Net Profit | $1.7M |
| Gross Margin | N/A |
| Operating Margin | -0.2% |
| Report Period | Q3 2025 |
CareDx, Inc. Annual Revenue by Year
CareDx, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $333.8M).
| Year | Annual Revenue |
|---|---|
| 2024 | $333.8M |
| 2023 | $280.3M |
| 2022 | $321.8M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.6M | $72.0M | $92.3M | $82.9M | $86.6M | $84.7M | $86.7M | $100.1M |
| YoY Growth | -20.4% | -6.7% | 31.3% | 23.4% | 32.0% | 17.5% | -6.1% | 20.7% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $466.8M | $452.4M | $466.8M | $477.0M | $491.1M | $489.6M | $444.3M | $432.3M |
| Liabilities | $205.5M | $196.2M | $202.1M | $203.7M | $112.6M | $110.3M | $116.9M | $121.2M |
| Equity | $261.3M | $256.2M | $264.7M | $273.2M | $378.4M | $379.3M | $327.4M | $311.1M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-8.4M | $-15.3M | $18.9M | $12.5M | $21.9M | $-26.6M | $9.9M | $37.4M |